Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DICERNA PHARMACEUTICALS, INC.

(DRNA)
Delayed Nasdaq  -  04:00:00 2021-12-27 pm EST
38.22 USD   +0.58%
2021Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisition
MT
2021Chardan Drops Coverage on Neutral-Rated Dicerna Pharmaceuticals on Acquisition by Novo Nordisk
MT
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) dropped from S&P Global BMI Index
CI
SummaryQuotesChartsNewsCompanyFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DICERNA PHARMACEUTICALS, INC.
2021Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisiti..
MT
2021Chardan Drops Coverage on Neutral-Rated Dicerna Pharmaceuticals on Acquisition by Novo ..
MT
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe..
CI
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe..
CI
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe..
CI
2021Novo Nordisk Completes Dicerna Pharmaceuticals Acquisition
MT
2021Dicerna Pharmaceuticals : Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acq..
PU
2021Novo Nordisk Closes on $3.3 Billion Acquisition of Dicerna Pharmaceuticals
MT
2021Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
BU
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe..
CI
2021Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of remai..
CI
2021Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk T..
BU
2021Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe..
CI
2021Chardan Downgrades Dicerna Pharmaceuticals to Neutral Rating From Buy on Proposed Acqui..
MT
2021Chardan Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts Price Target to..
MT
2021Insider Sell: Dicerna Pharmaceuticals
MT
2021Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38..
MT
2021Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day..
MT
2021North American Morning Briefing : Stock Futures -3-
DJ
2021B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B..
MT
2021RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $..
MT
2021HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38..
MT
2021Health Care Stocks Ending Little Changed in Quiet Trading
MT
2021Health Care Stocks Weakening This Afternoon
MT
2021Sector Update: Health Care
MT
2021Dicerna Shares Soar on Takeover by Novo Nordisk
DJ
2021Wall Street Set for Positive Open as Upbeat Nvidia Earnings Buoy Sentiment
MT
2021Health Care Stocks Edge Higher Premarket Thursday
MT
2021Sector Update: Health Care
MT
2021Dicerna Pharmaceuticals : Novo Nordisk to Acquire Dicerna - Form 8-K
PU
2021Top Premarket Gainers
MT
2021Novo Nordisk To Acquire Dicerna Pharmaceuticals
MT
2021Dicerna Pharmaceuticals Enters $3.3 Billion Deal to Be Acquired by Novo Nordisk
MT
2021Novo Nordisk to Buy Dicerna for $38.25 a Share
DJ
2021Novo Nordisk to Acquire Dicerna
BU
2021Novo Nordisk A/S (CPSE:NOVO B) entered into a definitive merger a..
CI
2021Dicerna Pharmaceuticals to Receive Multimillion-Dollar Milestone Payments Under Collabo..
MT
2021Dicerna Pharma : Two Targets in Lilly Collaboration Meet Proof of Princip..
DJ
2021Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodege..
BU
2021Dicerna Pharmaceuticals, Inc. Announces Two Targets Meet Preclinical Proof of Principle..
CI
2021Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the ..
BU
2021Dicerna Pharmaceuticals, Inc. Presents Data from Phase 1 Trial of Belcesiran At America..
CI
2021Dicerna Pharmaceuticals Narrows Q3 Net Loss as Revenue Rises
MT
2021Transcript : Dicerna Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 09, 20..
CI
2021Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update -..
PU
2021Dicerna Pharmaceuticals : Q3 Earnings Snapshot
AQ
2021Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Posts Q3 Revenue $63M, vs. Street Est of ..
MT
2021Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update
BU
2021Dicerna Presents PHYOX2 and Primary Hyperoxaluria Healthcare Utilization Data at Americ..
AQ
2021áDicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data a..
BU
2021Dicerna Pharmaceuticals, Inc. Presents PHYOX?2 and Primary Hyperoxaluria Healthcare Uti..
CI
2021Dicerna to Report Third Quarter 2021 Financial Results on Nov. 9, 2021
BU
2021Dicerna Pharmaceuticals : Announces Results for PHYOX4, Single-Dose Study of Nedosiran in ..
AQ
2021Dicerna Pharmaceuticals : Says Hyperoxaluria Treatment Met Safet..
MT
2021Dicerna Pharmaceuticals : Announces Results for PHYOX™4, Single-Dose Study of Nedosi..
BU
2021Dicerna Announces Results for PHYOXÖ4, Single-Dose Study of Nedosiran in Primary Hypero..
CI
2021Dicerna Pharmaceuticals : Announces Data to Be Presented at American Society of Nephrology..
BU
2021Dicerna Pharmaceuticals : to Present Phase 1 Data for Two Drug C..
MT
2021Dicerna Pharmaceuticals : Announces Poster Presentations at American Association for the S..
BU
2021Dicerna Pharmaceuticals, Inc. Announces Poster Presentations at American Association fo..
CI
2021Dicerna Pharmaceuticals : Corporate Overview
PU
2021Dicerna Pharmaceuticals : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
2021Dicerna Pharmaceuticals : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
AQ
2021Dicerna Pharmaceuticals : Begins Early-Stage Trial of Potential ..
MT
2021Dicerna Pharmaceuticals : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
BU
2021Dicerna Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of DCR-AUD
CI
2021Dicerna Pharmaceuticals : Names Rob Ciappenelli Chief Strategy O..
MT
2021Dicerna Pharmaceuticals : Announces New Executive Leadership Appointments
BU
2021Dicerna Pharmaceuticals, Inc. Announces Executive Appointments
CI
2021Insider Sell: Dicerna Pharmaceuticals
MT
2021Transcript : Dicerna Pharmaceuticals, Inc. Presents at Citi’s 16th Annua..
CI
2021Dicerna Pharmaceuticals : Corporate Overview
PU
2021Dicerna Pharmaceuticals : to Participate in 16th Annual Citi Biopharma Conference
BU
2021Dicerna Pharmaceuticals : Corporate Overview
PU
2021North American Morning Briefing: Stock Futures -3-
DJ
1  2  3  4  5  6  7  8  9  10Next
Stock markets for all
100% Free Registration
fermer